Novavax (NASDAQ:NVAX) Surprises With Strong Q4 CY2025 [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Its GAAP profit of $0.11 per share was significantly above analysts' consensus estimates. Is now the time to buy Novavax? Find out in our full research report Novavax (NVAX) Q4 CY2025 Highlights: Revenue: $147.1 million vs analyst estimates of $93.49 million (66.6% year-on-year growth, 57.4% beat) EPS (GAAP): $0.11 vs analyst estimates of -$0.49 (significant beat) Operating Margin: 9.7%, up from -148% in the same quarter last year Market Capitalization: $1.55 billion Company Overview Pioneering a nanoparticle technology that mimics the molecular structure of disease pathogens, Novavax (NASDAQ:NVAX) develops and commercializes protein-based vaccines for infectious diseases, with a primary focus on its COVID-19 vaccine and combination respiratory vaccine candidates. Revenue Growth A company's long-term sales performance can indicate its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Luckily,
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax (NVAX) had its price target raised by HC Wainwright from $11.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in Upcoming Investor ConferencesPR Newswire
- Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 2/26/26 - Form 8-K
- 2/26/26 - Form 10-K
- 2/11/26 - Form SCHEDULE
- NVAX's page on the SEC website